Monoclonal antibody against phosphatidylserine inhibits in vitro human trophoblastic hormone production and invasion

Biology of Reproduction

Volumn 56, Issue 1, 1997, Pages 50-58

  Katsuragawa, Hiroshi ^a   Kanzaki, Hideharu ^b   Inoue, Takuya ^a   Hirano, Takeshi ^a   Mori, Takahide ^a   Rote, Neal S ^c  

^a KYOTO UNIVERSITY   (Japan)

^b School of Medicine   (Japan)

^c WRIGHT STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN; CHORIONIC GONADOTROPIN; MATRIGEL; MONOCLONAL ANTIBODY; PHOSPHATIDYLSERINE;

ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELL INVASION; CYTOTROPHOBLAST; EXTRACELLULAR MATRIX; HORMONE SYNTHESIS; HUMAN; HUMAN TISSUE; MULTINUCLEAR CELL; PLACENTA; PRIORITY JOURNAL; THROMBOSIS; TROPHOBLAST;

ANTIBODIES, MONOCLONAL; CARDIOLIPINS; CELL DIFFERENTIATION; CELL SURVIVAL; CHORIONIC GONADOTROPIN; DECIDUA; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; PHOSPHATIDYLSERINES; PLACENTAL LACTOGEN; PREGNANCY; TROPHOBLASTS;

EID: 0031021017     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod56.1.50     Document Type: Article

References (55)

1. Branch DW, Scott JR, Kochenour NK, Hershgold E. Obstetric complications associated with the lupus anticoagulant. N Engl J Med 1985; 313:1322-1326.
2. Branch DW, Scott JR. Clinical implications of anti-phospholipid antibodies: the Utah experience. Jn: Harris EN, Exner T, Hughes GRV, Asherson RA (eds.), Phospholipid-Binding Antibodies. Boca Raton, FL: CRC Press: 1991: 335-346.
3. Rote NS. Transplacental alteration of fetal coagulation: antiphospholipid and antiplatelet antibodies. In: Bellisario R, Mizejewski GJ (eds.), Transplacental Disorders: Perinatal Detection, Treatment, and Management (including Pediatric AIDS). New York: Alan R. Liss, Inc.; 1990: 95-120.
4. Rote NS. Antiphospholipid antibodies and disorders of pregnancy. J Clin Immunoassay 1990; 13:34-42.
5. Rote NS, Ng AK, Ault KA, Carmody M, Dostal-Johnson DA, Mitchell J, Ng S, Roberts R, Siekman R. Antiphospholipid antibodies and recurrent pregnancy loss: analysis of monoclonal and polyclonal antiphosphatidylserine antibodies. In: Mettler L, Billington WD (eds.), Reproductive Immunology, 1989. Amsterdam: Elsevier Science Publishers; 1990: 217-226.
6. Rote NS, Walter A, Lyden TW. Antiphospholipid antibodies: lobsters or red herrings? Am J Reprod Immunol 1992; 28:31-37.
7. Scott JR, Rote NS, Branch DW. Immunologic aspects of recurrent abortion and fetal death. Obstet Gynecol 1987; 70:645-656.
8. Harris EN. Antiphospholipid antibodies. Br J Haematol 1990; 74:1-9.
9. Branch DW, Andres R, Digre KB, Rote NS, Scott JR. The association of antiphospholipid antibodies with severe preeclampsia. Obstet Gynecol 1989; 73:541-545.
10. Francois A, Freund M, Daffos F, Remy P, Aiach M, Jacquot C. Repeated fetal losses and the lupus anticoagulant. Ann Intern Med 1988; 109:993-994.
11. Kochenour NK, Branch DW, Rote NS, Scott JR. A new postpartum syndrome associated with antiphospholipid antibodies. Obstet Gynecol 1987; 69:460-468.
12. Kliman HJ, Feinman MA, Strauss III JF. Differentiation of human cytotrophoblasts into syncytiotrophoblasts in culture. Troph Res 1987; 2:407-421.
13. Katsuragawa H, Rote NS, Inoue T, Narukawa S, Kanzaki H, Mori T. Monoclonal antiphosphatidylserine antibody reactivity against human first-trimester placental trophoblasts. Am J Obstet Gynecol 1995; 172: 1592-1597.
14. Lyden TW, Vogt E, Ng AK, Johnson PM, Rote NS. Monoclonal antiphospholipid antibody reactivity against human placental trophoblast. J Reprod Immunol 1992; 22:1-14.
15. Rote NS, Lyden TW, Vogt E, Ng AK. Antiphospholipid antibodies and placental development. In: Hunt JS (ed.), Immunobiology of Reproduction. New York: Springer-Verlag; 1994: 285-302.
16. Boyd JD, Hamilton WJ. The Human Placenta. Cambridge: Heffer and Sons, Ltd.; 1970.
17. Lyden TW, Ng AK, Rote NS. Modulation of phosphatidylserine epitope expression on BeWo cells during forskolin treatment. Placenta 1993; 14:177-186.
18. Rote NS, Chang J, Katsuragawa H, Ng AK, Lyden TW, Mori T. Expression of phosphatidylserine-dependent antigens on the surface of differentiating BeWo human choriocarcinoma cells. Am J Reprod Immunol 1995; 33:114-121.
19. Rote NS, Ng AK. Anti-phospholipid antibodies and the placenta. In: Kurpisz M, Fernandez Z (eds.), Immunology of Human Reproduction. Oxford: ßios Scientific Publishers; 1995: 377-400.
20. Vogt E, Ng AK, Rote NS. A model for the antiphospholipid antibody syndrome: monoclonal antiphosphatidylserine antibody induces intra-uterine growth retardation in mice. Am J Obstet Gynecol 1996; 174: 700-707.
21. Katsuragawa H, Kanzaki H, Inoue T, Hirano T, Narukawa S, Watanabe H, Mori T. Endometrial stromal cell decidualization inhibits human chorionic gonadotropin and human placental lactogen secretion by co-cultured trophoblasts. Hum Reprod 1995; 10:3028-3034.
22. Rote NS, Ng AK, Dostal-Johnson DA, Nicholson SL, Siekman R. Immunologic detection of phosphatidylserine externalization during thrombin-induced platelet activation. Clin Immunol Immunopathol 1993; 66:193-200.
23. Inaji H, Yaoi E, Maeura Y, Matsuura N, Tominaga S, Koyama H, Takatsuka Y, Mori T. Carcinoembryonic antigen estimation in nipple discharge as an adjunctive tool in the diagnosis of early breast cancer. Cancer 1987; 60:3008-3013.
24. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65:55-63.
25. Carreras LO, Vermylen JG. "Lupus" anticoagulant and thrombosis -possible role of inhibition of prostacyclin formation. Thromb Haemostasis 1982; 48:38-40.
26. Marchesi D, Parbtani A, Frampton G, Livio M, Remuzzi G, Cameron JS. Thrombotic tendency in systemic lupus erythematosus. Lancet 1981; 1:719.
27. Ros JO, Tarres MV, Baucells MV, Maired JJ, Solano JT. Prednisone and maternal lupus anticoagulant. Lancet 1983; 2:576.
28. Walker TS, Triplett DA, Javed N, Musgrave K. Evaluation of lupus anticoagulants: antiphospholipid antibodies, endothelium associated immunoglobulin, endothelial prostacyclin secretion, and antigenic protein S levels. Thromb Res 1988; 51:267-281.
29. Cariou R, Tobelem G, Soria C, Caen J. Inhibition of protein C activation by endothelial cells in the presence of lupus anticoagulant. N Engl J Med 1986; 314:1193-1194.
30. Freyssinet JM, Wiesel ML, Gauchy J, Boneu B, Cazenave JP. An IgM lupus anticoagulant that neutralizes the enhancing effect of phospholipid on purified endothelial thrombomodulin activity - a mechanism for thrombosis. Thromb Haemostasis 1986; 55:309-313.
31. Cosgriff TM, Martin BA. Low functional and high antigenic anti-thrombin III level in a patient with the lupus anticoagulant and recurrent thrombosis. Arthritis Rheum 1981; 24:94-96.
32. Tannenbaum SH, Finko R, Cines DB. Antibody and immune complexes induce tissue factor production by endothelial cells. J Immunol 1986; 137:1532-1537.
33. DeWolf F, Carreras LO, Moerman P, Vermylen J, Van Assche A, Renaer M. Decidual vasculopathy and extensive placental infraction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. Am J Obstet Gynecol 1982; 142:829-834.
34. Out HJ, Kooijman CD, Bruinse HW, Derksen RHWM. Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies. Eur J Obstet Gynecol Reprod Biol 1991; 41:179-186.
35. Lochshin MD, Druzin ML, Goei S, Qamar T, Magid MS, Jovanovic L, Ferenc M. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med 1985; 313:152-156.
36. Althabe O, Labarrere C, Telenta M. Maternal vascular lesions in placentae of small-for-gestational-age infants. Placenta 1985; 6:265.
37. Sheppard BL, Bonnar J. An ultrastructural study of utero-placental spiral arteries in hypertensive and normotensive pregnancy and fetal growth retardation. Br J Obstet Gynecol 1981; 88:695.
38. Abramowsky CR, Vegas ME, Swinehart G, Gyves MT. Decidual vasculopathy of the placenta in lupus erythematosus. N Engl J Med 1980; 303:668-672.
39. Rote NS, Lyden TW, Vogt E, Adler RR, Chang J, Katsuragawa H, Lin L, Ng AK, Nicholson S, Patel PN, Shroyer L, Ponder D. Expression of phosphatidylserine epitopes during trophoblast membrane fusion: an alternative hypothesis for antiphospholipid antibody associated pregnancy disorders. In: Dondero F, Johnson PM (eds.), Reproductive Immunology. New York: Serono Symposia Publications, Raven Press; 1993; 97:281-284.
40. Taylor RN, Newman ED, Chen S. Forskolin and methotrexate induce an intermediate trophoblast phenotype in cultured human choriocarcinoma cells. Am J Obstet Gynecol 1991; 164:204-210.
41. Adler RR, Ng AK, Rote NS. Monoclonal antiphosphatidylserine antibody inhibits intercellular fusion of the choriocarcinoma line, JAR. Biol Reprod 1995; 53:905-910.
42. Rachmilewitz J, Gonik B, Goshen R, Ariel I, Schneider T, Eldar-Geva T, de Groot N, Hochberg A. Intermediate cells during cytotrophoblast differentiation in vitro. Cell Growth Differ 1993; 4:395-402.
43. Iwashita M, Watanabe M, Setoyama T, Mimuro T, Nakayama S, Adachi T, Takeda Y, Sakamoto S. Effects of diacylglycerol and gonadotropin-releasing hormone on human chorionic gonadotropin release by cultured trophoblast cells. Placenta 1992; 13:213-221.
44. Shi CZ, Zhuang LZ. Norepinephrine regulates human chorionic gonadotropin production by first trimester trophoblast tissue in vitro. Placenta 1993; 14:683-693.
45. Gleicher N, Harlow L, Zilberstein M. Regulatory effect of antiphospholipid antibodies on signal transduction: a possible model for autoantibody-induced reproductive failure. Am J Obstet Gynecol 1992; 167:637-642.
46. DiSimone N, DeCarolis S, Lanzone A, Rosisvalle E, Giannice R, Caruso A. In vitro effect of antiphospholipid antibody-containing sera on basal and gonadotropin releasing hormone-dependent human chorionic gonadotropin release by cultured trophoblast cells. Placenta 1995; 16:75-83.
47. Reza F, Igarashi K, Tokita S, Asai K, Aoki J, Asaoka Y, Umeda M, Inoue K. Anti-idiotypic monoclonal antibody recognizes a consensus recognition site for phosphatidylserine in phosphatidylserine-specific monoclonal antibody and protein kinase C. FEBS Lett 1994; 339:229-233.
48. Zhou Y, Damsky CH, Chiu K, Roberts JM, Fisher SJ. Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts. J Clin Invest 1993; 91:950-960.
49. Graham CH, Lala PK. Mechanisms of placental invasion of the uterus and their control. Biochem Cell Biol 1992; 70:867-874.
50. Sessions A, Horowitz AF. Myoblast aminophospholipid asymmetry differs from that of fibroblasts. FEBS Lett 1981; 134:75-78.
51. Sessions A, Horowitz AF. Differentiation related differences in the plasma membrane phospholipid asymmetry of myogenic and fibrogenic cells. Biochim Biophys Acta 1983; 728:103-111.
52. Bevers EM, Comfurius P, Zwaal RFA. Changes in membrane phospholipid distribution during platelet activation. Biochim Biophys Acta 1983; 736:57-66.
53. Thiagarajan P, Tait JF. Binding of annexin V/placental anticoagulant protein I to platelets. Evidence for phosphatidylserine exposure in the procoagulant response of activated platelets. J Biol Chem 1990; 265: 17420-17423.
54. Zwaal RFA, Bevers EM, Comfurius P, Rosing J, Tilly RH, Verhallen PF. Loss of membrane phospholipid asymmetry during activation of blood platelets and sickled red cells; mechanisms and physiological significance. Mol Cell Biochem 1989; 91:23-31.
55. Loke YW. Experimenting with human extravillous trophoblast: a personal view. Am J Reprod Immunol 1990; 24:21-28.